AstraZeneca, Alvogen fined in South Korea over alleged stalling of generic cancer drug Finances October 14, 2022 [ad_1] Roland Magnusson/iStock Editorial through Getty Photographs South Korea’s Truthful Commerce Fee (FTC) fined AstraZeneca (NASDAQ:AZN) and Alvogen 2.6B Korean…
